Menyeles

Salbutamol sulfate, the active ingredient in Menyeles, is a bronchodilator presented as a combination inhalation solution for inhalation use. It relaxes airway smooth muscle to improve breathing in patients with asthma and chronic obstructive pulmonary disease and helps reduce symptoms such as wheezing and shortness of breath.

GNH USA supplies Menyeles as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance, regulatory compliance and reliable global distribution and timely delivery to meet patient needs.

Menyeles, a combination bronchodilator, is used to manage obstructive airway diseases.

- Asthma: improves airflow and reduces acute bronchospasm. - Chronic obstructive pulmonary disease (COPD): alleviates bronchospasm and enhances lung function. - Acute bronchospasm: provides rapid relief of wheezing and shortness of breath.

Menyeles may cause a range of adverse reactions.

Common Side Effects: - Tremor - Headache - Throat irritation - Cough

Serious or Rare Side Effects: - Paradoxical bronchospasm - Angioedema - Cardiac arrhythmia

Before prescribing Menyeles, clinicians should consider several safety aspects.

- Assess respiratory status: confirm diagnosis and baseline lung function. - Monitor cardiovascular parameters: watch heart rate and blood pressure. - Use with caution in patients with known cardiovascular disease. - Avoid in individuals with documented hypersensitivity to salbutamol, ipratropium, or formulation excipients. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Menyeles can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Non‑selective β‑blockers: may diminish bronchodilator effect and precipitate bronchospasm. - Monoamine oxidase inhibitors (MAOIs): increase risk of cardiovascular stimulation. - Tricyclic antidepressants: may enhance tachycardia.

Moderate Interactions (Monitor Closely):\n- Theophylline: additive bronchodilator effect may increase side‑effects. - Other inhaled β2‑agonists: risk of cumulative tachycardia. - Anticholinergic agents: may increase anticholinergic load. - Diuretics: monitor electrolyte balance and blood pressure.